rs199828189

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001365276.2(TNXB):​c.9440-12_9440-10delTCT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00484 in 1,607,978 control chromosomes in the GnomAD database, including 160 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 138 hom. )

Consequence

TNXB
NM_001365276.2 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.249

Publications

1 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 6-32049596-GAGA-G is Benign according to our data. Variant chr6-32049596-GAGA-G is described in ClinVar as Benign. ClinVar VariationId is 261176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00554 (843/152252) while in subpopulation AMR AF = 0.031 (474/15304). AF 95% confidence interval is 0.0287. There are 22 homozygotes in GnomAd4. There are 480 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.9440-12_9440-10delTCT intron_variant Intron 27 of 43 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.10181-12_10181-10delTCT intron_variant Intron 28 of 44 NP_001415264.1
TNXBNM_019105.8 linkc.9434-12_9434-10delTCT intron_variant Intron 27 of 43 NP_061978.6 P22105-1O95680Q9Y464O95681

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.9440-12_9440-10delTCT intron_variant Intron 27 of 43 NM_001365276.2 ENSP00000496448.1 P22105-3
TNXBENST00000647633.1 linkc.10181-12_10181-10delTCT intron_variant Intron 28 of 44 ENSP00000497649.1 A0A3B3ISX9
TNXBENST00000375244.7 linkc.9440-12_9440-10delTCT intron_variant Intron 27 of 43 5 ENSP00000364393.3 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.00550
AC:
837
AN:
152134
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0306
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0208
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00246
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.0103
AC:
2483
AN:
241676
AF XY:
0.00785
show subpopulations
Gnomad AFR exome
AF:
0.000422
Gnomad AMR exome
AF:
0.0513
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0174
Gnomad FIN exome
AF:
0.00783
Gnomad NFE exome
AF:
0.00190
Gnomad OTH exome
AF:
0.00538
GnomAD4 exome
AF:
0.00476
AC:
6936
AN:
1455726
Hom.:
138
AF XY:
0.00436
AC XY:
3152
AN XY:
723404
show subpopulations
African (AFR)
AF:
0.000480
AC:
16
AN:
33300
American (AMR)
AF:
0.0454
AC:
2020
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
0.0000769
AC:
2
AN:
26006
East Asian (EAS)
AF:
0.0413
AC:
1634
AN:
39568
South Asian (SAS)
AF:
0.000325
AC:
28
AN:
86132
European-Finnish (FIN)
AF:
0.00761
AC:
396
AN:
52064
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5420
European-Non Finnish (NFE)
AF:
0.00241
AC:
2670
AN:
1108640
Other (OTH)
AF:
0.00283
AC:
170
AN:
60054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
404
809
1213
1618
2022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00554
AC:
843
AN:
152252
Hom.:
22
Cov.:
32
AF XY:
0.00645
AC XY:
480
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41552
American (AMR)
AF:
0.0310
AC:
474
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.0209
AC:
108
AN:
5174
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00659
AC:
70
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00246
AC:
167
AN:
67994
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00284
Hom.:
1
Bravo
AF:
0.00685
Asia WGS
AF:
0.00924
AC:
33
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Jul 22, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.36
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.36
Position offset: 39

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199828189; hg19: chr6-32017373; API